Mechanisms of Immune Evasion in PTEN Loss Prostate Cancer
<i>PTEN</i> (phosphatase and tensin homolog) is a frequently lost tumor suppressor gene in prostate cancer, leading to aggressive tumor behavior and poor clinical outcomes. <i>PTEN</i> loss results in aberrant activation of the PI3K/AKT/mTOR pathway, promoting oncogenesis. Th...
Saved in:
| Main Authors: | Jorge Esteban-Villarrubia, Pablo Alvarez Ballesteros, Miguel Martín-Serrano, María Ruiz Vico, Juan M Funes, Guillermo de Velasco, Elena Castro, David Olmos, Daniel Castellano, Enrique González-Billalabeitia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Immuno |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-5601/4/4/28 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management
by: Fidelis Charles Bugoye, et al.
Published: (2025-03-01) -
Sirolimus treatment of a PTEN hamartoma tumor syndrome presenting with melena
by: Gülseren Evirgen Şahin, et al.
Published: (2022-08-01) -
Candidiasis: Insights into Virulence Factors, Complement Evasion and Antifungal Drug Resistance
by: Nidaa Riaz Gaffar, et al.
Published: (2025-01-01) -
The emerging role of glycolysis and immune evasion in ovarian cancer
by: Bowen Jin, et al.
Published: (2025-03-01) -
Expression Profiles Of PTEN And POGZ Genes In Patients With Autism
by: Didem Öztop, et al.
Published: (2022-12-01)